Company Announcements

Directorate Change

Source: RNS
RNS Number : 8884G
Reckitt Benckiser Group PLC
29 July 2019

                                                                                                            29 July 2019




Mary Harris: Appointment as designated Non-Executive Director



Reckitt Benckiser Group plc is pleased to announce the appointment of Mary Harris, as designated Non-Executive Director, for engagement with the Company's workforce, in line with the provisions of the UK Corporate Governance Code 2018 (the "Code"), with effect from 26 July 2019.


Mary joined the Board in February 2015 and currently sits on the Nomination and Remuneration Committees, chairing the latter.


There are no additional details relating to the appointments that are required to be disclosed pursuant to Listing Rule 9.6.11(3).




For further Information:
Rupert Bondy

Company Secretary

Tel +44 (0) 1753 217 800


Richard Joyce

SVP, Investor Relations

Tel. +44 (0)1753 217 800



About RB:

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes. 

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. 

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide. 

For more information visit

 *RB is the trading name of the Reckitt Benckiser group of companies

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit